"This is the best use of my time to remain current with what is going on in the industry."
Voluntary Investigator Site Survey survey concluded with 528 responses.
This 13-page position paper on eSource (source data that has been captured by an electronic tool which is a replacement for paper) describes the regulatory environment for the ultimate benefit of all stakeholders involved in EDC.
The eClinical Forum has conducted a global survey of investigational site experiences and expectations with EDC. The survey covers: * Computer use and site facilities. * Current experience with EDC. * Satisfaction with EDC features. * Future expectations.
A survey was undertaken by the eClinical Forum to review the pharmaceutical industry’s experience to date with Electronic Data Capture (EDC) and to better understand future trends. The survey report incorporates the responses of 30 companies, and includes a mixture of EU and US ethical pharmaceutical and biotechnology companies representing 8 of the top 10, 12 of the top 20 and 18 of the top 40 by revenue.
eCF Spring 2026 Workshops Announced!
We are happy to announce our Spring workshops!
Europe/Hybrid: Hosted by Servier outside of Paris on April 14-16 (this will be livestreamed as well)
Americas: Hosted by YPrime outside of Philadelphia, PA on April 28-30
Asia: Hosted by Novartis in Tokyo, Japan on April 2-3
Release of the 2026 electronic Site Readiness Assessment (eSRA)
The latest version of eClinical Forum’s eSRA is now available for download, free and open to the industry. If you work at a clinical research site, eSRA is designed to help you. It's a standardized checklist that lets you evaluate your readiness to support electronic clinical trial processes before a study starts, so you can identify gaps early, not mid-trial.
Conclusion of the eCF Spring Workshops 2026
With the conclusion of the eClinical Forum Americas Workshop last week, the Spring 2026 workshop season has officially come to a close. This year’s workshops focused strongly on the current and future use of Artificial intelligence in clinical research. Planning for the Autumn 2026 Workshops will begin soon.